The Indian infection control market is projected to grow at a compound annual growth rate of 6.38% over the forecast period to attain a market size of US$347.045 million in 2027, from US$225.062 million in 2020. The facilitative visa regime, close and seamless coordination between the Ministry of Tourism and the Ministry of Home Affairs and Ministry of External Affairs of the Government of India and the growing influence of India’s heritage and other resources over the digital space has resulted in a tourism boom during recent years. As of December 2019, the e-visa facility has been extended to the nationals of 169 countries under 5 sub-categories, which are e-Business visa, e-Conference Visa, e-Medical Attendant Visa, and e-medical visa and e-Tourist visa. Further, there have been introductions such as the e-Tourist Visa for 5 years with multiple entries, in addition to the existing e-Tourist Visa for one year and a new category of e-Tourist Visa valid for one month. Triple entry is permitted for an e-Medical Visa and for an e-Medical Attendant Visa, and extension may be granted up to 6 months on a case-to-case basis on the merits of each Foreigners Regional Registration Officer (FRRO)/Concerned Foreigners Registration Officer (FRO) will review the matter. Medical Attendant Visa will be a co-terminus with the validity of the principal e-visa holder. The Ministry of Tourism has constituted Task Forces/Committees for the promotion of golf, medical/wellness, cruise, and adventure tourism in the country to promote niche tourism. Among the plethora of tourism options, one particular offering stands out, which is medical tourism, which is also internationally monikered as medical travel, health tourism, or global healthcare. Being a consumer-driven sector, the services are distinctively sought by patients who seek elective procedures as well as complex specialized surgeries such as joint replacement (knee/ hip), cardiac surgery, dental surgery, and cosmetic surgeries. Within the ambit of the mainstream healthcare segment, India offers a state-of-the-art medical facility staffed with reputed healthcare professionals as well as quality paramedical staff. Moreover, there is no waiting time for availing of medical services. Besides India also offers a myriad of alternative healthcare therapies like Ayurveda and Yoga, which combined with allopathic treatment provide holistic wellness. Further international platforms such as World Travel Mart, London, ITB, Berlin, and Arabian Travel Mart have been known to promote medical tourism.
Additionally, the Ministry of Tourism provides financial assistance under the Market Development Assistance Scheme (MDA) to approved wellness centres, i.e., representatives of wellness centres accredited by the National Accreditation Board of Hospitals (NABH) or the State Governments. As of 2018, the estimated foreign exchange earnings from tourism were US $25.8 billion [Source: Ministry of Tourism, Government of India]. Further, the total number of tourist arrivals was 1403 million with a value of 1448 US$ billion that was accounted for international tourism receipts. Therefore, from the aforementioned, it is discerned that despite being a market-driven segment, there has been substantial participation and proactive measures taken by regulatory authorities to catapult the tourism sector. Considering the growth of medical tourism and the influx of patients from foreign countries, the need for establishments providing food and beverage as well as accommodations, and the need for new healthcare points as well as legacy healthcare providers to observe and adhere to strict infection prevention measures have emerged as paramount importance. Therefore, it is anticipated that the need for infection prevention goods generated by both of these symbiotic industries (healthcare and tourism) will ignite the Indian infection control market to unprecedented heights during the forecast period.
COVID-19 Scenario
Due to the COVID-19 outbreak, there has been a sharp rise in the demand for infection control products in India. This has had a significant impact on the growth of the infection control market in Asia-Pacific as a result of the increased need for sterilisation and disinfection in hospitals and clinics, as well as in the pharmaceutical and medical device industries. Existence of numerous nonprofit and governmental institutions dedicated to raising infection control standards.
Key Development
| Report Metric | Details |
|---|---|
| Study Period | 2021 to 2031 |
| Historical Data | 2021 to 2024 |
| Base Year | 2025 |
| Forecast Period | 2026 – 2031 |
| Report Metric | Details |
| Market Size Value in 2020 | US$225.062 million |
| Market Size Value in 2027 | US$347.045 million |
| Growth Rate | CAGR of 6.38% from 2020 to 2027 |
| Base Year | 2020 |
| Forecast Period | 2022–2027 |
| Forecast Unit (Value) | USD Million |
| Segments Covered | Product, And End User Industry |
| Companies Covered | Getinge, 3M, MEDIVATORS Inc. (Cantel Medical Asia/Pacific Pte Ltd), Miele, Reckitt Benckiser (India) Ltd (Reckitt Benckiser Group plc), Tuttnauer |
| Customization Scope | Free report customization with purchase |
Segmentation: